RANI THERAPEUTICS HOLDINGS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-29.7M | $-30.0M | $-34.0M | $-30.6M | $-8.3M | $-16.7M |
| Depreciation & Amortization | $900.0K | $1.0M | $822.0K | $548.0K | $497.0K | — |
| Depreciation | $900.0K | $1.0M | $800.0K | $500.0K | $500.0K | $589.0K |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $11.8M | $16.0M | $19.0M | $15.8M | $22.6M | — |
| Net Cash from Operating Activities | $-18.7M | $-35.5M | $-51.2M | $-46.5M | $-32.2M | $-15.0M |
| Investing Activities | ||||||
| Capital Expenditures | $88.0K | $268.0K | $1.2M | $1.6M | $506.0K | $1.2M |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-7.0M | $19.8M | $29.9M | $-72.4M | $-506.0K | $-1.2M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $40.3M | $13.6M | $233.0K | $29.0M | $77.1M | $72.7M |
| Net Change in Cash | $14.6M | $-2.1M | $-21.1M | $-89.9M | $44.4M | $56.5M |
| Free Cash Flow | $-18.8M | $-35.8M | $-52.5M | $-48.1M | $-32.8M | $-16.2M |